Skip to content

A comparative clinical study on Madhyama Matra (Medium dose) and Avara Matra (Minimal dose) of Erandamooladi Niruha Basti (Medicated Enema) in Gridhrasi vis a vis Sciatica

A comparative clinical study on Madhyama Matra and Avara Matra of Erandamooladi Niruha Basti in Gridhrasi vis-a-vis Sciatica - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079546
Enrollment
40
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Sponsors

Dr Sreelakshmi Raj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of either gender in between the age group of 18-60 years. Subjects presenting with Lakshanas of Gridhrasi. Subjects presenting with the signs and symptoms of Sciatica. Subjects fit for Basti Karma.

Exclusion criteria

Exclusion criteria: Subjects with the history of any major systemic illness that may interfere with course of treatment. Subjects presenting with the history of traumatic, infective and neoplastic conditions of spine.

Design outcomes

Primary

MeasureTime frame
There is statistically significant difference between the groups on the following parameters namely ruk thoda sthamba muhurspandana tantra arochaka gaurava SLR test Bragards test bowstring testTimepoint: at baseline 8th day after treatment

Secondary

MeasureTime frame
NILTimepoint: NA

Countries

India

Contacts

Public ContactDr Kiran M Goud

Sri Kalabyraveshwara Swamy Ayurvedic Medical College Hospital and Research Centre

kiranmgoud@yahoo.co.in9845109556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026